Skip to content
  • HOME
  • ABOUT

    MADE IN AMERICA.

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • ADVOCACY
    • STAFF
    • BOARD
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT CPA
    • ABOUT CPA
    • ADVOCACY
    • STAFF
    • BOARD
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT CPA
    LEARN MORE ➔
  • RESEARCH

    RESEARCH HUB

    The CPA Economics Team is focused on research into policies that can restore broadly shared U.S. prosperity, reduce our huge trade deficit, raise U.S. economic growth rate and reduce inequality.

    VISIT THE RESEARCH HUB

    ECONOMIC ISSUES

    • Trade & Tariffs
    • International Currencies
    • Economic Modeling
    • Industrial Strategy & Industry Studies
    • Labor & Inequality
    • Trade & Tariffs
    • International Currencies
    • Economic Modeling
    • Industrial Strategy & Industry Studies
    • Labor & Inequality

    MORE FROM CPA ECONOMICS

    • JOB QUALITY INDEX
    • CPA Trade Database
    • Domestic Market Share Index
    • Working Papers & Policy Papers
    • JOB QUALITY INDEX
    • CPA Trade Database
    • Domestic Market Share Index
    • Working Papers & Policy Papers
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    CBO: Tariffs Bring Billions in Revenue, Barely Touch Inflation

    CBO: Tariffs Bring Billions in Revenue, Barely Touch Inflation

    June 18, 2025

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    CBO: Tariffs Bring Billions in Revenue, Barely Touch Inflation

    America’s Drug Shortage Isn’t a Supply Problem—It’s a Production Crisis

    Bessent Defends Tariffs in Senate Hearing, Calls Critics Sufferers of “Tariff Derangement Syndrome”

    Generic Drugs Need Government Support, House Health Subcommittee Admits

    MORE FROM THE NEWSROOM ➔
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

Latest China Company on Uyghur Law’s Banned List Counts USAA As Investor

Archive, Capital Markets, China, commentary, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaAugust 3, 2023Leave a comment

China companies are put on Entity Lists for being in breach of certain laws. In this case, allegations of forced labor. That doesn’t stop U.S. investors from buying their stocks.

Inflation Reduction Act Brings Solar Investments to the US. WSJ Unimpressed.

Archive, commentary, Commentary Featured, Featured Home Page, Issues, Manufacturing, Newsroom, Renewable EnergyBy Kenneth RapozaAugust 2, 2023Leave a comment

Companies continue to invest in domestic solar thanks to all the new renewable energy tax credits. Without them, and tariffs, US solar would be China owned.

Senate Takes Turn to End China Profiting Off of U.S. Federal Pensions

Archive, Capital Markets, China, commentary, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJuly 24, 2023Leave a comment

Should federal government employees, including military commanders, be investing their retirement money in China? Some say no, and will try to stop it this week.

Government Pension Fund Managers Invested In China Fail To Preserve Retirement Savings

Archive, Capital Markets, commentary, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJuly 17, 2023Leave a comment

Some in the Senate want to ban China from government retirement funds. Wall Street thinks it’s their fiduciary duty to be in China, despite losing money.

Government Incentives for Niche Sectors of Economy Leads to “Manufacturing Boom”

Archive, Commentary Featured, Featured Home Page, Issues, Newsroom, Trade and TariffsBy Kenneth RapozaJuly 10, 2023Leave a comment

The recent spending on manufacturing facilities is almost entirely due to two pieces of legislation. That won’t be enough for a real, manufacturing boom.

Are Americans Investing in Chinese Forced Labor Companies?

Archive, Capital Markets, China, commentary, Commentary Featured, Customs, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 23, 2023Leave a comment

The House Select Committee on the CCP published a preliminary report on the use of forced labor in Shein and Temu supply chains. Many Americans are investors.

Taiwan Agreement Risks Treasury Rewriting Customs Law Globally

Featured Home Page, commentary, Commentary Featured, Newsroom, Trade and TariffsBy Charles BenoitJune 21, 2023Leave a comment

On June 1, 2023, the United States and Taiwan signed “the first agreement under the U.S.-Taiwan Initiative on 21st Century Trade.” “Initiative”? “21st Century Trade”?

FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US

Archive, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJune 9, 2023Leave a comment

A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?

To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs

Archive, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.

Five China Companies Wall Street Still Funds Despite Being Blacklisted

Archive, Capital Markets, Commentary Featured, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 2, 2023Leave a comment

Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.

←1
234567891011121314151617181920212223
…2425262728…
293031323334353637383940
41→
  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Youtube Linkedin

© 2025 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • RESEARCH
    • RESEARCH HUB
    • CPA ECONOMIC VIEW
    • TRADE & TARIFFS
    • CURRENCIES
    • MODELING
    • INDUSTRIAL STRATEGIES
    • LABOR & INEQUALITY
    • ECONOMICS CHARTS
    • ECONOMICS PRESENTATIONS
    • CURRENCY MISALIGNMENT MONITOR
    • DOMESTIC MARKET SHARE INDEX
    • TRADE DATABASE
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Twitter
 Facebook
 LinkedIn
 Copy
 Email

Share on Mastodon